Steven Cohen Incyte Corp Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Incyte Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 477,073 shares of INCY stock, worth $49.7 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

477,073

Previous 985,083 51.57%

Holding current value

$49.7 Million

Previous $67.1 Million 39.69%

% of portfolio

0.08%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$67.27 - $86.96 $34.2 Million - $44.2 Million	-508,010 Reduced 51.57%	477,073 $40.5 Million
Q2 2025 Aug 14, 2025	BUY	$55.17 - $71.22 $35.5 Million - $45.8 Million	643,069 Added 188.02%	985,083 $67.1 Million
Q1 2025 May 15, 2025	SELL	$60.0 - $75.26 $56.2 Million - $70.5 Million	-936,355 Reduced 73.25%	342,014 $20.7 Million
Q4 2024 Feb 14, 2025	SELL	$65.08 - $83.38 $71 Million - $91 Million	-1,090,931 Reduced 46.04%	1,278,369 $88.3 Million
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $136 Million - $163 Million	2,369,300 New	2,369,300 $157 Million

Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $21.5 Million - $25.3 Million	380,100 New	380,100 $21.7 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $15.8 Million - $19.1 Million	-239,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $15.1 Million - $17.7 Million	239,000 New	239,000 $17.5 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $37.1 Million - $49 Million	-487,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $18.3 Million - $22.1 Million	226,689 Added 86.85%	487,700 $42.4 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $22.2 Million - $28.6 Million	261,011 New	261,011 $23.4 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $34.5 Million - $50.7 Million	-465,161 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $26.2 Million - $35.7 Million	414,861 Added 824.77%	465,161 $34.1 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $3.67 Million - $4.81 Million	50,300 New	50,300 $4.39 Million
Q3 2019 Nov 15, 2019	SELL	$72.82 - $86.52 $14,563 - $17,304	-200 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $5.59 Million - $6.74 Million	-76,039 Reduced 99.74%	200 $17,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $113,009 - $156,766	1,778 Added 2.39%	76,239 $6.56 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $4.15 Million - $4.96 Million	-70,877 Reduced 48.77%	74,461 $4.74 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $71.3 Million - $85.7 Million	-1,154,335 Reduced 88.82%	145,338 $10 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $75.7 Million - $105 Million	1,244,673 Added 2263.04%	1,299,673 $87.1 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $1.25 Million - $1.51 Million	-15,000 Reduced 21.43%	55,000 $4.58 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $8.85 Million - $11 Million	-94,600 Reduced 57.47%	70,000 $6.63 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $18 Million - $22.8 Million	164,600	164,600 $19.2 Million

Others Institutions Holding INCY

# of Institutions

797

Shares Held

205M

Call Options Held

638K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account